NovoCure Limited logo
NovoCure Limited NVCR
$ 16.62 9.27%

Annual report 2025
added 02-26-2026

report update icon

NovoCure Limited EV/EBITDA Ratio 2011-2026 | NVCR

Annual EV/EBITDA Ratio NovoCure Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-243 417 1.1 K -176 -64.3 -4.73 -2.81 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.1 K -243 146

EV/EBITDA Ratio of other stocks in the Health care industry

Issuer EV/EBITDA Ratio Price % 24h Market Cap Country
Anthem Anthem
ANTM
19.2 - -2.32 % $ 107 B usaUSA
CVS Health Corporation CVS Health Corporation
CVS
16.2 $ 82.09 -1.45 % $ 104 B usaUSA
Triple-S Management Corporation Triple-S Management Corporation
GTS
79.5 - 0.28 % $ 847 M usaUSA
Magellan Health, Inc. Magellan Health, Inc.
MGLN
16.1 - -0.19 % $ 2.49 B usaUSA
UnitedHealth Group Inc. UnitedHealth Group Inc.
UNH
21.6 $ 368.78 -0.46 % $ 335 B usaUSA
Centene Corporation Centene Corporation
CNC
26.4 $ 53.34 -0.61 % $ 26.3 B usaUSA
Molina Healthcare Molina Healthcare
MOH
20.4 $ 192.7 -0.99 % $ 10.2 B usaUSA
Cigna Corporation Cigna Corporation
CI
9.45 $ 282.9 -2.7 % $ 74.5 B usaUSA
Humana Humana
HUM
21.3 $ 233.63 -1.29 % $ 28.1 B usaUSA